1289 related articles for article (PubMed ID: 19416245)
21. A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis.
Schwarz T; Kreiselmaier I; Bieber T; Thaci D; Simon JC; Meurer M; Werfel T; Zuberbier T; Luger TA; Wollenberg A; Bräutigam M
J Am Acad Dermatol; 2008 Jul; 59(1):34-40. PubMed ID: 18462835
[TBL] [Abstract][Full Text] [Related]
22. Skin physiological parameters confirm the therapeutic efficacy of pimecrolimus cream 1% in patients with mild-to-moderate atopic dermatitis.
Aschoff R; Schwanebeck U; Bräutigam M; Meurer M
Exp Dermatol; 2009 Jan; 18(1):24-9. PubMed ID: 18637133
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
Kirsner RS; Heffernan MP; Antaya R
Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
[TBL] [Abstract][Full Text] [Related]
24. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
25. Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients.
Oppel T; Pavicic T; Kamann S; Bräutigam M; Wollenberg A
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1175-80. PubMed ID: 17894701
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
Ho VC; Gupta A; Kaufmann R; Todd G; Vanaclocha F; Takaoka R; Fölster-Holst R; Potter P; Marshall K; Thurston M; Bush C; Cherill R
J Pediatr; 2003 Feb; 142(2):155-62. PubMed ID: 12584537
[TBL] [Abstract][Full Text] [Related]
27. Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis.
Papp K; Staab D; Harper J; Potter P; Puig L; Ortonne JP; Molloy S; Barbier N; Paul C;
Int J Dermatol; 2004 Dec; 43(12):978-83. PubMed ID: 15569038
[TBL] [Abstract][Full Text] [Related]
28. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study.
Gueniche A; Knaudt B; Schuck E; Volz T; Bastien P; Martin R; Röcken M; Breton L; Biedermann T
Br J Dermatol; 2008 Dec; 159(6):1357-63. PubMed ID: 18795916
[TBL] [Abstract][Full Text] [Related]
29. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.
Meurer M; Eichenfield LF; Ho V; Potter PC; Werfel T; Hultsch T
J Dermatolog Treat; 2010 May; 21(3):157-66. PubMed ID: 20394491
[TBL] [Abstract][Full Text] [Related]
30. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
[TBL] [Abstract][Full Text] [Related]
31. Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis.
Meurer M; Fartasch M; Albrecht G; Vogt T; Worm M; Ruzicka T; Altmeyer PJ; Schneider D; Weidinger G; Braeutigam M;
Dermatology; 2004; 208(4):365-72. PubMed ID: 15178928
[TBL] [Abstract][Full Text] [Related]
32. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.
Papp KA; Werfel T; Fölster-Holst R; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
J Am Acad Dermatol; 2005 Feb; 52(2):240-6. PubMed ID: 15692468
[TBL] [Abstract][Full Text] [Related]
33. Improvement in pruritus in children with atopic dermatitis using pimecrolimus cream 1%.
Fowler J; Johnson A; Chen M; Abrams K
Cutis; 2007 Jan; 79(1):65-72. PubMed ID: 17330625
[TBL] [Abstract][Full Text] [Related]
34. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
[TBL] [Abstract][Full Text] [Related]
35. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
Karabulut AA; Izol Serel B; Eksioglu HM
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
[TBL] [Abstract][Full Text] [Related]
36. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants.
Kaufmann R; Fölster-Holst R; Höger P; Thaçi D; Löffler H; Staab D; Bräutigam M;
J Allergy Clin Immunol; 2004 Nov; 114(5):1183-8. PubMed ID: 15536429
[TBL] [Abstract][Full Text] [Related]
37. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis.
Fleischer AB; Abramovits W; Breneman D; Jaracz E;
J Dermatolog Treat; 2007; 18(3):151-7. PubMed ID: 17538803
[TBL] [Abstract][Full Text] [Related]
38. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
39. StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid.
Gollnick H; Luger T; Freytag S; Bräutigam M;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1319-25. PubMed ID: 18540990
[TBL] [Abstract][Full Text] [Related]
40. Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study.
Ring J; Abraham A; de Cuyper C; Kim K; Langeland T; Parra V; Pigatto P; Reunala T; Szczepanski R; Möhrenschlager M; Bräutigam M; Rossi AB; Meents-Kopecky E; Schneider D
J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):195-203. PubMed ID: 18211413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]